Pain Management Devices Market Competitive Scenario With
Impact Of Drivers And Challenges 2027
Pain management devices are designed to ease chronic pain from conditions, like
fibromyalgia, diabetic neuropathy, sciatica, and osteoarthritis. Some of these devices
deploy infrared light energy to relieve pain, by tapping into the body’s natural pain
response and blocking the pain signals. All the pain management devices are designed
to help relieve muscular and joint pains, improve blood circulation, cope with migraines
and arthritis, or deal with the aches and pains of a long day at work, or at the gym.
Growing demand for long-term pain management among the geriatric population, large
patient population base, and adverse effects of pain medications are some of the key
factors that have increased the demand for the pain management devices market.
These drug-free devices often have little to no side effects and this guide will allow you
to browse different treatment options at a glance. Each product has benefits – for
starters, you don’t need to be at the doctor’s office to use these devices and you get to
be in charge of when and how often you put them to use – as well as drawbacks (like
cost), so talk to your doctor if you think one might be a good fit for you.
Get Free PDF Brochure of this Report
Key players in the global pain management devices market include Medtronic PLC,
Becton, Dickinson and Company, ST. Jude Medical, Inc., Boston Scientific
Corporation, Hospira, Inc. (A Subsidiary of Pfizer Inc.), Halyard Health, Inc.,
Smiths Medical, B. Braun Melsungen AG, Neurotech Na, Inc., and Nevro Corp.
The players have adopted product development strategies to strengthen their position
in the market. For instance, in January 2019, Boston Scientific Corporation launched
Spectra WaveWriter, a new spinal cord stimulation device in Europe market. The newly
launched devices by the company are the only devices available in the